Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.017 seconds
Tachikawa, Kimihito; Nishiyama, Naotaka; Muranaka, Takashi; Takada, Koichi; Murase, Kazuyuki; Kouno, Tsutomu; Junji, Kato; Masumori, Naoya, E-mail: nishiyan@sapmed.ac.jp2018
AbstractAbstract
[en] We report the case of a patient who achieved complete remission (CR) of cisplatin-refractory metastatic pure seminoma after treatment with high-dose carboplatin and etoposide (CE) with peripheral blood stem cell transplantation as fourth-line chemotherapy. A 38-year-old man was diagnosed with advanced pure seminoma (pT3N3M1aS3). In the international germ cell consensus classification, his prognosis was classified as intermediate. He was treated with high-dose CE as fourth-line chemotherapy after treatment with BEP, VeIP, and TIN. After two cycles of high-dose CE, the concentrations of T-HCG and other tumor markers showed normal levels. A CT scan and PET–CT showed that the lymph node swelling had disappeared and there was no uptake. The CR has continued for 27 months after the treatment. High-dose CE might be less toxic and have a better prognostic outcome than other treatments as salvage chemotherapy for patients with cisplatin-refractory advanced testicular cancer.
Primary Subject
Source
Copyright (c) 2018 The Japan Society of Clinical Oncology; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
International Cancer Conference Journal; ISSN 2192-3183;
; v. 7(1); p. 6-10

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue